Epigenetic Modifications in the Pathogenesis of Systemic Sclerosis

被引:8
|
作者
Yu, Jiangfan [1 ]
Tang, Rui [2 ]
Ding, Ke [3 ]
机构
[1] Cent South Univ, Xiangya Hosp 2, Dept Dermatol, Changsha 410011, Peoples R China
[2] Cent South Univ, Xiangya Hosp 2, Dept Rheumatol & Immunol, Changsha 410011, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Dept Urol, Changsha 410008, Peoples R China
基金
中国国家自然科学基金;
关键词
systemic sclerosis; pathogenesis; epigenetics; biomarkers; DERMAL FIBROBLASTS; COLLAGEN EXPRESSION; DNA METHYLATION; GENE-EXPRESSION; EMERGING ROLE; SCLERODERMA; HISTONE; INTERFERON; CELLS; ACTIVATION;
D O I
10.2147/IJGM.S356877
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic sclerosis is a rare chronic autoimmune disease, which mainly manifests as immune disorders, vascular damage, and progressive fibrosis. The etiology of SSc is complex and involves multiple factors. Both genetic and environmental factors are involved in its pathogenesis. As one of the molecular mechanisms of environmental factors, epigenetic regulation plays an important role in the occurrence and development of systemic sclerosis, which involves DNA methylation, histone modification and non-coding RNA regulation. This review summarizes research advances in epigenetics, including exosomes, lncRNA, and mentions possible biomarkers and therapeutic targets among them.
引用
收藏
页码:3155 / 3166
页数:12
相关论文
共 50 条
  • [1] Epigenetic modifications: novel therapeutic strategies for systemic sclerosis?
    Juengel, Astrid
    Distler, Joerg H. W.
    Gay, Steffen
    Distler, Oliver
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (04) : 475 - 480
  • [2] The Role of Epigenetic Modifications in Systemic Sclerosis: A Druggable Target
    Henderson, John
    Distler, Joerg
    O'Reilly, Steven
    TRENDS IN MOLECULAR MEDICINE, 2019, 25 (05) : 395 - 411
  • [3] An updated review on abnormal epigenetic modifications in the pathogenesis of systemic lupus erythematosus
    Zhou, Xingyu
    Zhou, Shengnan
    Li, Yaping
    FRONTIERS IN IMMUNOLOGY, 2025, 15
  • [4] Epigenetic mechanisms driving the pathogenesis of systemic lupus erythematosus, systemic sclerosis and dermatomyositis
    Zhang, Yusheng
    Bermudez, Narges Maskan
    Sa, Brianna
    Maderal, Andrea D.
    Jimenez, Joaquin J.
    EXPERIMENTAL DERMATOLOGY, 2024, 33 (01)
  • [5] Epigenetic Modifications in the Pathogenesis of Diabetic Nephropathy
    Reddy, Marpadga A.
    Park, Jung Tak
    Natarajan, Rama
    SEMINARS IN NEPHROLOGY, 2013, 33 (04) : 341 - 353
  • [6] Epigenetic mechanisms: An emerging role in pathogenesis and its therapeutic potential in systemic sclerosis
    Luo, Yangyang
    Wang, Yong
    Shu, Ye
    Lu, Qianjin
    Xiao, Rong
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2015, 67 : 92 - 100
  • [8] Pathogenesis of systemic sclerosis
    Fabri, M.
    Krieg, T.
    HAUTARZT, 2007, 58 (10): : 838 - +
  • [9] Pathogenesis of systemic sclerosis
    Pattanaik, Debendra
    Brown, Monica
    Postlethwaitel, Bradley C.
    Postlethwaite, Arnold E.
    FRONTIERS IN IMMUNOLOGY, 2015, 6
  • [10] Pathogenesis of systemic sclerosis
    Takehara, K
    JOURNAL OF RHEUMATOLOGY, 2003, 30 (04) : 755 - 759